Adiponectin is a critical regulator of flow-mediated vasodilation in resistance arterioles of skeletal muscle

Obesity is a major risk factor in the progression of many cardiovascular diseases and often contributes to the disruption microvascular health mainly through endothelial dysfunction. Adiponectin, which is the most abundant adipokine, regulates endothelial function by regulating ceramide and sphingosine-1-phosphate (S1P) signaling. More specifically, adiponectin binds to cell surface receptors (AdipoR1 and AdipoR2) and activates endothelial ceramidase activity, which converts ceramide to S1P. This is critical because ceramide promotes production of reactive oxygen species, while S1P enhances the activity of endothelial nitric oxide synthase, which supports mechanotransduction and endothelium-dependent vasodilation. Therefore, we hypothesized that acute depletion of adiponectin impairs endothelium-dependent, flow-induced vasodilation by disrupting S1P signaling. To investigate this, first-order arterioles (70–125 μm) from the gastrocnemius muscle of adult male and female WT or inducible adiponectin knockout (AdipoKO) mice were isolated for evaluation of vasodilatory responses to intraluminal flow at constant pressure. Flow-induced vasodilation was evaluated at baseline and in the presence of N, N-Dimethylsphingosine (DMS) to block S1P production. At baseline, flow-induced vasodilation was significantly lower in arterioles from AdipoKO mice as compared to arterioles from WT mice. Blockade of S1P with DMS substantially reduced flow-induced vasodilation in arterioles from both male and female WT mice, indicating a strong reliance on S1P signaling. DMS also decreased flow-induced dilation in arterioles from male and female AdipoKO mice, but to a lesser degree than in WT mice. S1P inhibition eliminated the differences in flow-induced vasodilation in arterioles from male WT and AdipoKO mice. In contrast, in arterioles from female mice, in the presence of S1P inhibition, flow-induced vasodilation was lower in WT as compared to AdipoKO mice. These results indicate that acute depletion of adiponectin diminishes flow-mediated vasodilation of skeletal muscle arterioles. Furthermore, this impairment of flow-mediated vasodilation, induced by acute knockout of adiponectin, is associated with sex-specific disruption of S1P signaling. Taken together, our study highlights the critical role of adiponectin in regulating endothelial S1P signaling, which in turn governs mechanotransduction and endothelium-dependent vasodilation in skeletal muscle arterioles. NIH R01HL166591 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Authors

Institutions

Publication Details

Journal
Physiology
Published
2025-05-01
DOI
https://doi.org/10.1152/physiol.2025.40.s1.0366
Primary Topic
Cardiovascular Disease and Adiposity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adiponectin is a critical regulator of flow-mediated vasodilation in resistance arterioles of skeletal muscle

Jose Renato Pinto, Kyle Kraeher, Steven Medarev, Judy M. Muller‐Delp et al.
Physiology
Cardiovascular Disease and Adiposity
article

Adiponectin is a critical regulator of flow-mediated vasodilation in resistance arterioles of skeletal muscle

Jose Renato Pinto, Kyle Kraeher, Steven Medarev, Judy M. Muller‐Delp, Jasen Balenko, Alison Murdoch, Anthony Ogando, Chad Shillito, Sydney Blakeney, Diego Mendoza-Jacobo, Justin Ojah-Maharaj
article en

Abstract

Obesity is a major risk factor in the progression of many cardiovascular diseases and often contributes to the disruption microvascular health mainly through endothelial dysfunction. Adiponectin, which is the most abundant adipokine, regulates endothelial function by regulating ceramide and sphingosine-1-phosphate (S1P) signaling. More specifically, adiponectin binds to cell surface receptors (AdipoR1 and AdipoR2) and activates endothelial ceramidase activity, which converts ceramide to S1P. This is critical because ceramide promotes production of reactive oxygen species, while S1P enhances the activity of endothelial nitric oxide synthase, which supports mechanotransduction and endothelium-dependent vasodilation. Therefore, we hypothesized that acute depletion of adiponectin impairs endothelium-dependent, flow-induced vasodilation by disrupting S1P signaling. To investigate this, first-order arterioles (70–125 μm) from the gastrocnemius muscle of adult male and female WT or inducible adiponectin knockout (AdipoKO) mice were isolated for evaluation of vasodilatory responses to intraluminal flow at constant pressure. Flow-induced vasodilation was evaluated at baseline and in the presence of N, N-Dimethylsphingosine (DMS) to block S1P production. At baseline, flow-induced vasodilation was significantly lower in arterioles from AdipoKO mice as compared to arterioles from WT mice. Blockade of S1P with DMS substantially reduced flow-induced vasodilation in arterioles from both male and female WT mice, indicating a strong reliance on S1P signaling. DMS also decreased flow-induced dilation in arterioles from male and female AdipoKO mice, but to a lesser degree than in WT mice. S1P inhibition eliminated the differences in flow-induced vasodilation in arterioles from male WT and AdipoKO mice. In contrast, in arterioles from female mice, in the presence of S1P inhibition, flow-induced vasodilation was lower in WT as compared to AdipoKO mice. These results indicate that acute depletion of adiponectin diminishes flow-mediated vasodilation of skeletal muscle arterioles. Furthermore, this impairment of flow-mediated vasodilation, induced by acute knockout of adiponectin, is associated with sex-specific disruption of S1P signaling. Taken together, our study highlights the critical role of adiponectin in regulating endothelial S1P signaling, which in turn governs mechanotransduction and endothelium-dependent vasodilation in skeletal muscle arterioles. NIH R01HL166591 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

PhysiologyVol. 40(S1)
Florida State University (US), Kansas State University (US)
Openalex Percentile: Top 74%
Cardiovascular Disease and Adiposity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.